Jeffrey W. Dunn has served as our President and Chief Executive Officer and as the Chairman of our board of directors since our inception in April 2008. Prior to joining SI BONE, Mr. Dunn served as Chief Executive Officer of INBONE Technologies, Inc., an ankle replacement and small bone fusion

Laura A. Francis has served as our Chief Financial Officer since May 2015. Prior to joining SI BONE, Ms. Francis was the Chief Financial Officer for Auxogyn, Inc., a women’s health company, from December 2012 to September 2014. From September 2004 to December 2012, Ms.

Anthony J. Recupero has served as our Chief Commercial Officer since July 2016. Prior to joining us, Mr. Recupero was the President of Catalyst Performance Advisors, LLC, where he advised leading medical device companies on commercial strategy from June 2013 to July 2016. In July 2008, Mr.

Michael A. Pisetsky has served as our General Counsel and Chief Compliance Officer since August 2016. Mr. Pisetsky joined us in March 2015 as our Director of Legal. From August 2011 to March 2015, Mr. Pisetsky practiced law privately, serving as General Counsel to New Wave Surgical Corp.

W. Carlton Reckling, MD has served as our Vice President, Medical Affairs since April 2012 and our Chief Medical Officer since February 2017. From July 1994 to April 2012, Dr. Reckling was a spine surgeon at the Spine Center in Loveland, Colorado, Rocky Mountain Orthopedic Specialists in Cheyenne,

Scott A. Yerby, PhD has served as our Chief Technology Officer since January 2011. Prior to joining us, Dr. Yerby served as Vice President, Research and Development for ProMed, Inc., a medical supply company, from June 2009 to January 2011. From May 2007 to June 2009, Dr.

Michael C. Blanchard has served as Vice President of Operations since December 2018, has been with SI-BONE since March 2014, and oversees Quality, IT, Supply Chain Management. Mr. Blanchard has extensive medical device experience in materials management, purchasing, logistics, ERP/MRP systems, and

Daniel J. Cher, MD has served as our Vice President, Clinical Affairs since January 2012. From May 2008 to December 2011, Dr. Cher served as Vice President of Clinical and Regulatory Affairs at Chestnut Medical Technologies, Inc., a company developing new minimally invasive therapies for

Nikolas F. Kerr has served as our Vice President, Product Management since August 2016. Prior to joining us, Mr. Kerr was President of Kerr Consulting Group where he advised leading medical device companies on product strategy. Previously, Mr. Kerr was Senior Director of Marketing for Benvenue

Joyce brings over 20 years of financial management and accounting experience to SI-BONE. Prior to joining SI-BONE, she was the chief accounting officer at BioPharmX, a public, specialty pharmaceutical company focused on dermatology indications, until its acquisition by Timber Pharmaceuticals.

Andrea Mercanti has served as our Vice President, EMEA Operations since May 2013, and he previously served as our Vice President, European Operations from September 2010 to April 2013. Prior to joining us, Mr. Mercanti was General Director for Italy of MBA Incorporado, an orthopedic, spine and

Joseph W. Powers has served as our Vice President, Marketing since August 2012. Previously, Mr. Powers served as our Senior Director, Business Development from January 2012 to July 2012 and as our Western Area Sales Director from December 2009 to December 2011. Prior to joining us, Mr.

Bruce Prothro has served as the Vice President of Regulatory Affairs since March 2019. Mr. Prothro has over 30 years of experience in Regulatory Affairs, Quality Assurance, and Clinical Research and has worked in both small and large MedTech companies.

Troy S. Wahlenmaier has served as our Vice President of U.S. Sales since January 2018.  Mr. Wahlenmaier joined us in February 2012, serving in sales management positions and earning promotions to Western Area Director of Sales in July 2014 and Senior Director of National Sales in July 2016.  Mr.

Jeffrey D. Zigler has served as our Vice President, Market Access and Reimbursement since January 2019. Prior to joining us, Mr. Zigler led the Reimbursement and Health Economics team at LDR Spine, until its acquisition in 2016 by Zimmer Biomet, a global orthopedics technology company, where he